Allstate Corp Invests $278,000 in Henry Schein, Inc. (NASDAQ:HSIC)

Allstate Corp purchased a new stake in Henry Schein, Inc. (NASDAQ:HSIC) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 4,022 shares of the company’s stock, valued at approximately $278,000.

A number of other large investors have also recently bought and sold shares of HSIC. Norges Bank bought a new position in shares of Henry Schein during the fourth quarter valued at $103,301,000. Raymond James Financial Inc. bought a new position in Henry Schein during the 4th quarter valued at about $34,720,000. National Bank of Canada FI boosted its position in Henry Schein by 1,124.5% in the third quarter. National Bank of Canada FI now owns 535,950 shares of the company’s stock valued at $39,071,000 after buying an additional 492,181 shares in the last quarter. ING Groep NV grew its stake in Henry Schein by 34.1% during the fourth quarter. ING Groep NV now owns 1,163,087 shares of the company’s stock worth $80,486,000 after buying an additional 295,785 shares during the last quarter. Finally, Wolverine Asset Management LLC acquired a new stake in shares of Henry Schein during the fourth quarter worth approximately $12,179,000. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Price Performance

HSIC opened at $69.25 on Thursday. The company has a fifty day moving average price of $74.31 and a two-hundred day moving average price of $72.65. The firm has a market capitalization of $8.60 billion, a PE ratio of 28.50, a P/E/G ratio of 2.13 and a beta of 0.84. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.49. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. During the same period last year, the firm earned $0.66 earnings per share. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. As a group, analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Analyst Upgrades and Downgrades

HSIC has been the topic of a number of research analyst reports. Barrington Research restated an “outperform” rating and set a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. Mizuho assumed coverage on Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price for the company. UBS Group reduced their price target on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 26th. Jefferies Financial Group raised their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Finally, Wells Fargo & Company began coverage on shares of Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 target price on the stock. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $81.10.

Insider Activity

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the business’s stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the firm’s stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at approximately $4,460,251.20. This represents a 6.05 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.